Nurse Explains How Socioeconomics May Influence Cancer Outcomes

Nurse Explains How Socioeconomics May Influence Cancer Outcomes

Race and economics are still driving cancer treatment and survivorship, ONS member Janice Phillips, RN, PHD, FAAN, explained in her article, “Unfair Diagnosis: Socioeconomic Gap Drives Cancer Outcomes,” published in January 2019 in Scientific American.

Newsroom

Building Collaboration, Education With Oncology Nurses in Malawi

Building Collaboration, Education With Oncology Nurses in Malawi

Nestled between Tanzania and Mozambique in eastern Africa, Malawi is a country of more than 18 million citizens. It faces a unique cancer burden that’s proven challenging for practitioners and patients alike. With a high prevalence of HIV-infected individuals, Malawi sees a proportionate rate of AIDS-related cancers, including Kaposi sarcoma, cervical cancer, and non-Hodgkin lymphoma. Currently, healthcare professionals in the country face a lack of standardized oncology education and resources. Roughly 84% of the country’s citizens live in rural areas with limited access to healthcare institutions.

Government Shutdown Ends; FDA Threatens E-Cigarettes; New Medicare Part D; Uninsured Rates Rise

Government Shutdown Ends; FDA Threatens E-Cigarettes; New Medicare Part D; Uninsured Rates Rise

After a contentious 35-day-long shutdown, President Trump announced on January 25, 2019, plans for a temporary deal to reopen the government for a three-week period while talks continue on border security and immigration. Neither party seems optimistic that compromise can happen by the February 15 deadline, and the future is still uncertain.

Study Finds Three Priority Steps to Improve Cancer Survivorship

Study Finds Three Priority Steps to Improve Cancer Survivorship

Healthcare providers need to address three priority areas to improve outcomes for cancer survivors and support caregivers for patients with cancer, according to findings from an evidence review published in CA: A Cancer Journal for Clinicians.

Oncology Drug Reference Sheet: Lutetium Lu 177 Dotatate

Oncology Drug Reference Sheet: Lutetium Lu 177 Dototate

Lutetium Lu 177 dototate (Lutathera®) was approved in January 2018 by the U.S. Food and Drug Administration to treat a specific group of neuroendocrine tumors (NETs) in the gastrointestinal tract. NETs are rare, and the tumors produce hormone-like substances in response to signals from the nervous system.

Opioids Have Been a Healthcare Concern Since the 1980s, but Here’s How Nurses Can Help

Opioids Have Been a Healthcare Concern Since the 1980s

Although the opioid crisis was formally labeled a public health emergency in late 2017, excess drug abuse beyond prescription directions has been a public health concern for much longer—since the 1980s, in fact. At the November 2018 Center for Advancing Palliative Care Annual Seminar in Orlando, FL, speakers Lynn Hallarman and Mary McPherson presented a session on how the opioid crisis came to be and what our role as nurses is in changing culture and ultimately addressing it.

Pre-Existing Condition Resolution; Teen Vaping; Drug Pricing Talks

Pre-Existing Condition Resolution; Teen Vaping; Drug Pricing Talks

Debates like the one facing the constitutionality of the Affordable Care Act (ACA) are what American democracy is built on. Checks and balances for each branch of government—often with authority undulating back to state governments—provide numerous opportunities for policy issues to change and develop through legislative, regulatory, and judicial review. Recently, U.S. Senator Patty Murray (D-WA) and Senator Maria Cantwell (D-WA) have reintroduced a resolution that authorizes Senate Legal Counsel to defend Americans with preexisting conditions against a Republican Attorneys General lawsuit facing the ACA.

VA Specialist Shortage; Rising Drug Prices; King Won't Seek Reelection

VA Specialist Shortage; Rising Drug Prices; King Won't Seek Reelection

On the heels of celebrating our nation’s servicemembers on Veterans Day, the U.S. Department of Veterans Affairs (VA) issued a report that indicated it was struggling to treat veterans with cancer because of a lack of healthcare specialists. For years, the VA has faced challenges with filling hospital job openings in all positions. The resulting administrative and oversight issues are only hurting those most in need of its services. To find out that cancer incidence rates are higher in those who’ve been a part of active war zones—and that the agency is unable to meet their needs—is a sad state for our nation’s vets.

The Role of the APRN in Monitoring Patients Receiving Peptide Receptor Radionuclide Therapy

The Role of the APRN in Monitoring Patients Receiving Peptide Receptor Radionuclide Therapy

Neuroendocrine cancers are rare malignancies; however, their incidence is thought to be increasing. Such tumors are characterized by their overexpression of somatostatin receptors, present in up to 80% of cases. However, a novel radiopharmaceutical may give advanced practice RNs (APRNs) a new option to treat certain gastroenteropancreatic neuroendocrine tumors.